Company Quick10K Filing
Monro
10-Q 2020-12-26 Filed 2021-02-04
10-Q 2020-09-26 Filed 2020-11-05
10-Q 2020-06-27 Filed 2020-08-06
10-K 2020-03-28 Filed 2020-06-12
10-Q 2019-12-28 Filed 2020-02-06
10-Q 2019-09-28 Filed 2019-11-07
10-Q 2019-06-29 Filed 2019-08-08
10-K 2019-03-30 Filed 2019-05-29
10-Q 2018-12-29 Filed 2019-02-07
10-Q 2018-09-29 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-09
10-K 2018-03-31 Filed 2018-05-30
10-Q 2017-12-23 Filed 2018-02-01
10-Q 2017-09-23 Filed 2017-11-02
10-Q 2017-06-24 Filed 2017-08-03
10-K 2017-03-25 Filed 2017-05-24
10-Q 2016-12-24 Filed 2017-02-02
10-Q 2016-09-24 Filed 2016-11-03
10-Q 2016-06-25 Filed 2016-08-04
10-K 2016-03-26 Filed 2016-05-25
10-Q 2015-12-26 Filed 2016-02-04
10-Q 2015-09-26 Filed 2015-11-05
10-Q 2015-06-27 Filed 2015-08-06
10-K 2015-03-28 Filed 2015-05-27
10-Q 2014-12-27 Filed 2015-02-05
10-Q 2014-09-27 Filed 2014-11-06
10-Q 2014-06-28 Filed 2014-08-07
10-K 2014-03-29 Filed 2014-05-28
10-Q 2013-12-28 Filed 2014-02-04
10-Q 2013-09-28 Filed 2013-10-31
10-Q 2013-06-29 Filed 2013-07-30
10-K 2013-03-30 Filed 2013-05-29
10-Q 2012-12-29 Filed 2013-02-07
10-Q 2012-09-29 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-09
10-K 2012-03-31 Filed 2012-05-30
10-Q 2011-12-24 Filed 2012-02-02
10-Q 2011-09-24 Filed 2011-11-03
10-Q 2011-06-25 Filed 2011-08-04
10-K 2011-03-26 Filed 2011-05-25
10-Q 2010-12-25 Filed 2011-02-03
10-Q 2010-09-25 Filed 2010-10-29
10-Q 2010-06-26 Filed 2010-08-02
10-K 2010-03-27 Filed 2010-06-10
10-Q 2009-12-26 Filed 2010-02-04
8-K 2020-11-24
8-K 2020-11-04
8-K 2020-10-28
8-K 2020-08-18
8-K 2020-08-01
8-K 2020-07-29
8-K 2020-06-11
8-K 2020-05-28
8-K 2020-05-27
8-K 2020-04-11
8-K 2020-03-27
8-K 2020-02-14
8-K 2020-01-30
8-K 2019-10-24
8-K 2019-09-30
8-K 2019-08-13
8-K 2019-07-25
8-K 2019-05-21
8-K 2019-04-25
8-K 2019-03-21
8-K 2019-02-20
8-K 2019-01-31
8-K 2018-10-25
8-K 2018-10-08
8-K 2018-09-27
8-K 2018-08-14
8-K 2018-07-31
8-K 2018-07-26
8-K 2018-06-28
8-K 2018-05-21
8-K 2018-04-17
8-K 2018-03-26
8-K 2018-03-05
8-K 2018-02-16
8-K 2018-01-30

Monro Financials

MNRO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 41 77% -17.5 -11% 226 289 73 56 -25 -14 243
Clovis Oncology (CLVS) 219 0% -0.0 -56% 717 804 134 0 -400 -394 18
Cementos Pacasmayo Saa (CPAC) 4,145 0% 2,863 1,412 0 0 0 0 4,145
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 123 1.0 0% 962 869 0 0 3 15 14
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-252011-09-242011-12-242012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-242017-03-252017-06-242017-09-232017-12-232018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-30
Cash53231281125128588148576976821324696
Accounts Receivable
Inventory10310610197105110115118115121124125127143136130133135131129135146137143146147143152158157159171174171
PP&E401408414424432436465500505513524532546570581592600619631640657678693713726740757768786792807827647658
Assets4884964985105635766707127047347617607789049099089329981,0039991,0561,1541,1631,1851,1921,2091,2131,2181,2621,2631,2671,3121,5781,620
Accounts Payable44494945504953616160605354716863675769706076817992938685918995104105108
Long-Term Debt636243514348124128104119112106106152146123118145127103141198185182158153155148158151120138160169
Liabilities193188177183225227315346324343357344347459451434439489479463506590589604598602599590618600581613860886
Stockholders' Equity
Income Statement ($MM)2011-06-252011-09-242011-12-242012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-242017-03-252017-06-242017-09-232017-12-232018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-30
Revenue165173177172169176190196206205217203218221237219237239239229237249288252278278286286296307310287317324
Cost of Revenue94102109105101107121125127124134126127132146135137138146137139149183159166170179178179187192177189202
Gross Profit7171686668707071798282779089908410010193929810010693113108107108117120118110128122
R&D
SG&A
Tax1098677648897101010812128810101051011127664576
Net Income1515141112121181414151217161613191915141718181018171217212221172320
Cash Flow ($MM)2011-06-252011-09-242011-12-242012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-242017-03-252017-06-242017-09-232017-12-232018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-30
Cash Operating299331219113421341328193421343832143645224634284134225026245821
Cash Investing-36-7-11-11-55-12-97-30-7-23-13-12-27-55-26-10-24-40-11-9-55-92-13-15-11-21-12-39-21-30-69-20
Cash Financing10-4-231342703-2611-12-11-640-11-25-719-23-323148-22-10-33-13-8-1-15813-3